GDRX Stock Cash Flow Statements

GoodRx Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

GoodRx Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31

cash flows from operating activities
net income	12,843,000	11,052,000	6,740,000	3,965,000	6,694,000	-1,009,000	-25,869,000	-38,495,000	58,786,000	-3,290,000	-1,972,000	-41,734,000	-1,415,000	12,293,000	-39,914,000	-18,069,000	31,061,000	1,668,000	-298,274,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	19,729,000	20,912,000	19,096,000	17,535,000	16,965,000	15,942,000	43,608,000	33,024,000	16,097,000	14,939,000	15,533,000	13,952,000	13,319,000	11,373,000	10,648,000	10,161,000	8,369,000	5,361,000	4,404,000
amortization of debt issuance costs and discounts	439,000	430,000
non-cash operating lease expense	979,000	1,086,000	1,203,000	1,051,000	1,035,000	895,000	1,082,000	967,000	1,013,000	1,042,000	1,035,000	805,000	782,000	727,000	651,000	660,000	919,000	872,000	1,047,000
stock-based compensation expense	21,415,000	19,174,000	20,959,000	26,381,000	26,590,000	25,096,000	28,778,000	32,646,000	17,897,000	25,499,000	29,414,000	29,038,000	31,633,000	30,149,000	33,280,000	39,980,000
loss on operating lease asset	0	4,409,000
other	170,000	286,000
changes in operating assets and liabilities:
accounts receivable	-28,910,000	-14,183,000	-15,131,000	30,971,000	-17,005,000	-1,161,000	-22,462,000	2,232,000	-6,936,000	699,000	3,745,000	1,992,000	836,000	-5,198,000	-19,569,000	-11,507,000	-7,203,000	-5,670,000	-5,211,000
prepaid expenses and other assets	-2,309,000	-13,487,000	18,595,000	-6,287,000	-9,320,000	3,339,000	-2,295,000	-16,293,000	-7,569,000	-6,005,000	-10,507,000	5,302,000	-12,055,000	3,616,000	11,364,000	52,937,000	-37,397,000	-9,844,000	-9,103,000
accounts payable	10,800,000	286,000	1,926,000	-5,150,000	-15,565,000	-2,452,000	2,941,000	25,487,000	-6,235,000	-4,737,000	7,137,000	-6,151,000	2,582,000	-4,442,000	-115,000	-595,000	-26,000	4,943,000	-1,257,000
accrued expenses and other current liabilities	15,844,000	-19,079,000	5,931,000	17,805,000	1,049,000	924,000	-4,818,000	7,653,000	17,234,000	1,184,000	-14,365,000	11,186,000	15,108,000	-17,197,000	8,690,000	7,208,000	-1,830,000	-67,000	1,247,000
operating lease liabilities	-1,559,000	-1,628,000	-1,703,000	-1,480,000	-1,766,000	-4,000	-1,470,000	-795,000	-525,000	-140,000	-589,000	-1,259,000	-928,000	-1,228,000	-903,000	-911,000	-1,221,000	631,000	2,935,000
other liabilities	139,000	155,000	-2,022,000	223,000	198,000	179,000	416,000	-1,806,000	1,899,000	405,000	-412,000	2,937,000	35,000	-435,000	-1,249,000	38,000	71,000	429,000	1,374,000
net cash from operating activities	49,580,000	9,413,000	44,743,000	86,862,000	9,701,000	42,586,000	15,868,000	60,270,000	29,866,000	32,288,000	31,879,000	33,732,000	51,049,000	30,120,000	49,810,000	48,558,000	34,926,000	45,485,000	14,850,000
capex	-18,315,000	-21,876,000	-16,644,000	-15,859,000	-17,229,000	-20,615,000	-12,872,000	-13,647,000	-14,959,000	-8,537,000	-15,290,000	-13,775,000	-13,731,000	-12,418,000	-9,259,000	-8,510,000	-6,993,000	-9,695,000	-9,810,000
free cash flows	31,265,000	-12,463,000	28,099,000	71,003,000	-7,528,000	21,971,000	2,996,000	46,623,000	14,907,000	23,751,000	16,589,000	19,957,000	37,318,000	17,702,000	40,551,000	40,048,000	27,933,000	35,790,000	5,040,000
cash flows from investing activities
purchase of property and equipment	-390,000	-142,000	-162,000	-403,000	-268,000	-407,000	-409,000	-194,000	-292,000	-148,000	-150,000	-645,000	-1,436,000	-1,736,000	-807,000	-706,000	-343,000	-2,715,000	-4,872,000
acquisition	0	-30,000,000
capitalized software	-17,925,000	-21,734,000	-16,482,000	-15,456,000	-16,961,000	-20,208,000	-12,463,000	-13,453,000	-14,667,000	-14,140,000	-15,140,000	-13,130,000	-12,295,000	-10,682,000	-8,452,000	-7,804,000	-6,650,000	-6,980,000	-4,938,000
net cash from investing activities	-18,315,000	-51,876,000	-16,644,000	-15,859,000	-17,229,000	-20,615,000	-12,872,000	-13,647,000	-14,959,000	-14,288,000	1,286,000	-13,775,000	-163,608,000	-34,401,000	-9,259,000	-27,058,000	-132,721,000	-9,695,000	-9,810,000
cash flows from financing activities
payments on long-term debt	-1,250,000	-1,250,000	0	-633,765,000	-1,757,000	-3,516,000	1,000	-1,757,000	-1,757,000	-1,758,000	-1,757,000	-1,757,000	-1,757,000	-1,758,000	-1,757,000	-1,757,000	-1,758,000	-1,757,000	-29,757,000
repurchases of class a common stock	-45,991,000	-99,897,000	-188,000	-5,431,000	0	-153,226,000	-77,825,000	-7,712,000	-8,920,000	-9,517,000	0	-17,956,000	0	-83,765,000
proceeds from exercise of stock options	1,000	2,000	611,000	6,663,000	9,188,000	2,584,000	1,556,000	3,118,000	559,000	708,000	49,000	1,271,000	4,156,000	3,683,000	5,306,000	14,234,000	13,109,000	2,372,000	195,000
employee taxes paid related to net share settlement of equity awards	-4,548,000	-3,757,000	-4,862,000	-8,956,000	-9,152,000	-6,814,000	-50,078,000	-7,355,000	-4,525,000	-3,523,000	-3,078,000	-3,269,000	-4,727,000	-9,561,000	-15,014,000	-16,657,000	-11,384,000	-14,633,000
proceeds from employee stock purchase plan			909,000	0			741,000	0
net cash from financing activities	-50,928,000	-104,902,000	-3,530,000	-172,129,000	-864,000	-160,972,000	-125,605,000	-13,706,000	-13,994,000	-14,090,000	-4,786,000	-21,711,000	-2,328,000	-91,401,000	-11,465,000	-4,180,000	-865,000	-14,018,000	-111,373,000
net change in cash and cash equivalents	-19,663,000	-147,365,000	24,569,000	-101,126,000	-8,392,000	-139,001,000	-122,609,000	32,917,000	913,000	3,910,000
cash and cash equivalents
beginning of period	0	448,346,000		0	0	672,296,000	0	0	0	757,165,000	0	0	0	941,109,000	0	0	0	971,591,000
end of period	-19,663,000	300,981,000		-101,126,000	-8,392,000	533,295,000	-122,609,000	32,917,000	913,000	761,075,000	28,379,000	-1,754,000	-114,887,000	845,427,000	29,086,000	17,320,000	-98,660,000	993,363,000
supplemental disclosure of cash flow information
non cash investing and financing activities:
right-of-use assets obtained in exchange for operating lease liabilities
stock-based compensation included in capitalized software	4,465,000	4,138,000		4,223,000	4,295,000	3,795,000	3,223,000	3,700,000	3,457,000	2,764,000	2,011,000	3,113,000	1,833,000	2,012,000
capitalized software included in accounts payable and accrued expenses and other current liabilities	1,334,000	5,311,000		2,887,000	252,000	4,376,000	2,037,000	1,557,000	1,607,000	2,625,000
loss on extinguishment of debt			0
amortization of debt issuance costs			421,000	413,000	826,000	837,000	843,000	844,000	846,000	849,000	851,000	852,000	854,000	856,000	859,000	859,000	864,000	863,000	960,000
change in fair value of contingent consideration											1,200,000	16,617,000							1,167,000
deferred income taxes			-11,272,000				-7,573,000	4,991,000	-63,015,000	35,000	-356,000	195,000	58,000	-394,000	46,068,000	-32,853,000	-137,000	-227,000	-13,202,000
gain on sale of business
loss on operating lease assets							979,000	0
loss on disposal of capitalized software							360,000
loss on minority equity interest investment							0	2,200,000	0	1,808,000
changes in operating assets and liabilities, net of effects of business acquisitions
acquisitions, net of cash acquired											0	0			0	-14,540,000			0
investment in minority equity interest											0	0	0	-15,007,000	0
proceeds from sale of business
proceeds from long-term debt			0																0
payments of debt issuance costs			0
changes in operating assets and liabilities
capitalized software transferred from prepaid assets							0	0	0	5,751,000
payments for contingent consideration
income tax paid (refunds received)
interest paid
right-of-use assets obtained in exchange for new operating lease liabilities											20,180,000	0			2,387,000	52,000			0
changes in operating assets and liabilities, net of effects of business acquisition
acquisition, net of cash acquired														-6,976,000
charitable stock donation
proceeds from issuance of common stock in initial public offering, net of underwriting discounts and commissions																			0
proceeds from private placement with a related party
payment of debt issuance costs and prepayment penalty
payment for contingent consideration															0	0
payments of initial public offering issuance costs																			-3,097,000
proceeds from early exercise of stock options																			0
net change in cash, cash equivalents and restricted cash											28,379,000	-1,754,000	-114,887,000	-95,682,000	29,086,000	17,320,000	-98,660,000	21,772,000	-106,333,000
cash, cash equivalents and restricted cash
conversion of preferred stock to common stock in connection with initial public offering
loss on abandonment of operating lease assets																650,000
loss on abandonment and impairment of operating lease assets
issuance of common stock
income tax (refunds received) paid
purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities
proceeds from private placement
payment of debt issuance costs
non cash investing and financing activities
offering costs included in accounts payable and accrued expense and other current liabilities
stock-based compensation included in capitalized software development costs																2,613,000	1,690,000	1,728,000	875,000
capitalized software development costs in accounts payable and accrued expenses and other current liabilities																306,000
employee tax withholding obligations on stock option exercises included in accrued expenses and other current liabilities
stock-based compensation																		46,526,000	286,081,000
capitalized software development costs in accrued expenses and other current liabilities																		615,000	98,000
changes in operating assets and liabilities, net of effect of business acquisitions
issuance of preferred stock
dividends paid
beginning of year
end of year
cash paid during the year for
income taxes
interest
conversion of preferred stock to common stock
offering costs included in accounts payable and accrued expenses and other current liabilities

We provide you with 20 years of cash flow statements for GoodRx stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of GoodRx stock. Explore the full financial landscape of GoodRx stock with our expertly curated income statements.

The information provided in this report about GoodRx stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.